<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) have been implicated in regulating diverse cellular pathways </plain></SENT>
<SENT sid="1" pm="."><plain>Although there is emerging evidence that various miRNAs function as oncogenes or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), the role of miRNAs in mediating <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> remains unexplored </plain></SENT>
<SENT sid="2" pm="."><plain>The expression profile of miRNAs in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues was analyzed by miRNA microarrays and verified by real-time polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="3" pm="."><plain>In 62 CRC patients, the expression levels of miR-320a were determined by real-time PCR, and the effects on migration and invasion of miR-320a were determined using a transwell assay </plain></SENT>
<SENT sid="4" pm="."><plain>miR-320a target genes were confirmed by luciferase assay, real-time PCR and western blot analysis </plain></SENT>
<SENT sid="5" pm="."><plain>A set of miRNAs was found to be dysregulated in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> tissues compared to matched primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues, and the expression levels of miR-320a were significantly decreased in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> tissues examined </plain></SENT>
<SENT sid="6" pm="."><plain>miR-320a was correlated with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>miR-320a was downregulated in liver metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells and inhibited liver metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell migration and invasion </plain></SENT>
<SENT sid="8" pm="."><plain>miR-320a directly binds to the 3'UTR of neuropilin 1 (NRP-1), a protein that functions as a co-receptor of vascular epithelial growth factor </plain></SENT>
<SENT sid="9" pm="."><plain>miR-320a downregulated the expression of NRP-1 at both the <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels </plain></SENT>
<SENT sid="10" pm="."><plain>These data demonstrated that miR-320a may be useful for identifying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients that are at an elevated risk for developing <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings suggest that miR-320a may be a novel therapeutic candidate for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>